MILWAUKEE – In what could be a boon to development of vaccines and targeted therapies, a researcher at the University of Wisconsin-Madison, in collaboration with a team of international researchers, has created a streamlined, hardy form of the bacteria E. coli by reducing its DNA to its bare essentials.
Office of Strategic Communication